The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils.
Open accessAbstract
Thrombin stimulation of human platelets results in the release of a preformed proteinaceous human eosinophil (Eo)-chemotactic activity. By the use of different high-performance liquid chromatography techniques, two Eo-chemotactic polypeptides (EoCPs), tentatively termed EoCP-1 and EoCP-2, were purified to homogeneity. Upon SDS-PAGE analysis, these chemotaxins showed molecular masses near 8 kD. NH2-terminal amino acid sequence analysis revealed identical sequences for both EoCP-1 and EoCP-2, which are also identical to that of RANTES, a cytokine that structurally belongs to the interleukin 8 superfamily of leukocyte selective attractants, and that is known to be a "memory-type" T lymphocyte-selective attractant. In the major Eo chemotaxin, EoCP-1, the residues 4 and 5, which in EoCP-2 were found to be serine residues, could not be identified. Electrospray mass spectrometry (ESP-MS) of EoCPs revealed for EoCP-2 a molecular mass of 7,862.8 +/- 1.1 daltons, which is 15.8 mass units higher than the calculated value of RANTES, indicating that EoCP-2 is identical to the full-length cytokine, and oxygenation, probably at methionine residue number 64, has taken place. Upon ESP-MS, EoCP-1 showed an average molecular mass of 8,355 +/- 10 daltons, suggesting O-glycosylation at these serine residues. Both natural forms of RANTES showed strong Eo-chemotactic activity (ED50 = 2 nM) with optimal chemotactic migration at concentrations near 10 nM, however, there were no significant migratory responses with human neutrophils. Chemotactic activity of RANTES for human Eos could be confirmed using recombinant material, which has been found to be as active as the natural forms. Since RANTES gene expression has been detected in activated T lymphocytes, and recombinant RANTES was shown to be a "memory" T lymphocyte-selective attractant, it is now tempting to speculate about an important role of RANTES in clinical situations such as allergene-induced late-phase skin reactions in atopic subjects or asthma, where in affected tissues both memory T cells and Eos are characteristic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114265 · Cited by 1,975
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,379
The Neutrophil-Activating Protein (NAP-1) Is Also Chemotactic for T Lymphocytes
Larsen, C. G., Anderson, A. O., Appella, E., Oppenheim, J. J., & Matsushima, K. (1989) · Science · doi:10.1126/science.2648569 · Cited by 1,038
Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., & Leonard, E. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9233 · Cited by 982
Matsushima, K., Larsen, C. G., DuBois, G. C., & Oppenheim, J. J. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1485 · Cited by 756
Biology of the rantes/sis cytokine family
Schall, T. J. (1991) · Cytokine · doi:10.1016/1043-4666(91)90013-4 · Cited by 673
Yoshimura, T., Yuhki, N., Moore, S. K., Appella, E., Lerman, M. I., & Leonard, E. J. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80590-3 · Cited by 589
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
Wardlaw, A. J., Moqbel, R., Cromwell, O., & Kay, A. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112765 · Cited by 568
Schröder, J. M., Mrowietz, U., Morita, E., & Christophers, E. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.10.3474 · Cited by 531
Self-citationA human T cell-specific molecule is a member of a new gene family.
Schall, T. J., Jongstra, J., Dyer, B. J., Jorgensen, J., Clayberger, C., Davis, M. M., & Krensky, A. M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.1018 · Cited by 495
Van Damme, J., Van Beeumen, J., Opdenakker, G., & Billiau, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.4.1364 · Cited by 314
Amino acid sequence of human platelet factor 4.
Deuel, T. F., Keim, P. S., Farmer, M., & Heinrikson, R. L. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.6.2256 · Cited by 310
Yoshimura, T., Robinson, E. A., Tanaka, S., Appella, E., & Leonard, E. J. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.6.1956 · Cited by 308
Recombinant human interleukin 5 is a selective eosinophil chemoattractant
Wang, J. M., Rambaldi, A., Biondi, A., Chen, Z. G., Sanderson, C. J., & Mantovani, A. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190420 · Cited by 306
Neutrophil-activating properties of the melanoma growth-stimulatory activity.
Moser, B., Clark-Lewis, I., Zwahlen, R., & Baggiolini, M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1797 · Cited by 285
Walz, A., Dewald, B., von Tscharner, V, & Baggiolini, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.5.1745 · Cited by 221
Rand, T. H., Cruikshank, W. W., Center, D. M., & Weller, P. F. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.6.1521 · Cited by 205
Castor, C. W., Miller, J. W., & Walz, D. A. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.3.765 · Cited by 176
Walz, A., & Baggiolini, M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.2.449 · Cited by 163
Schröder, J. M., Persoon, N., & Christophers, E. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.4.1091 · Cited by 149
Self-citationEosinophils and T-lymphocytes in late-phase allergic reactions
Frew, A. J., & Kay, A. B. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(90)90090-q · Cited by 128
Walz, A., & Baggiolini, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92203-1 · Cited by 107
Giri, J. G. (1992) · Cytokine · doi:10.1016/1043-4666(92)90031-l · Cited by 30
Cited by
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines
Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,671
C hemokines in I nnate and A daptive H ost D efense : Basic Chemokinese Grammar for Immune Cells
Rot, A., & von Andrian, U. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104543 · Cited by 1,215
Jose, P. J., Griffiths-Johnson, D. A., Collins, P. D., Walsh, D. T., Moqbel, R., Totty, N. F., Truong, O., Hsuan, J. J., & Williams, T. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.881 · Cited by 806
Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor
Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R., & Schall, T. J. (1993) · Cell · doi:10.1016/0092-8674(93)90118-a · Cited by 763
Metadata
- Authors
- Kameyoshi, Y., Dörschner, A., Mallet, A. I., Christophers, E., & Schröder, J. M.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1992-08-01
- Volume
- 176
- Issue
- 2
- Pages
- 587-592
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2143800769
- Cited by
- 670
- References
- 23
- FWCI
- 18.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.